NewGenIVF Group Plunges 9.47% Amid Medical Tourism Expansion

On May 28, 2025, NewGenIVF Group experienced a significant drop of 9.47% in pre-market trading, reflecting a notable shift in investor sentiment towards the company.

NewGenIVF Group has been actively expanding its services, particularly in the medical tourism sector. The company's subsidiary, First Fertility PGS Center, has launched culturally tailored fertility services in Thailand, aiming to attract a growing number of medical tourists from the region. This strategic move is part of a broader initiative to enhance the company's presence in the global fertility treatment market.

In addition to its expansion in Thailand, NewGenIVF Group has also set its sights on the Indian market. The company has initiated a strategic growth plan through its subsidiary, First Fertility PGS Center, to attract Indian medical tourists. This plan includes targeted marketing efforts and the development of specialized services to meet the unique needs of Indian patients.

These strategic expansions are indicative of NewGenIVF Group's commitment to growing its market share in the fertility treatment industry. By focusing on key medical tourism destinations, the company aims to leverage the increasing demand for assisted reproductive services and establish itself as a leading provider in the global market.